The conversation has evolved. In 2026, we are no longer just asking if we can extend the human healthspan—we are actively building the world that supports it. We have moved beyond “living longer” to living better through AI-driven medicine, robust financial infrastructure, and strategic investment.
The Cyprus EMEA Healthspan is a high-level event designed for those at the helm of the longevity transition.
It bridges the gap between the frontier of longevity science and the global capital required to scale it.
Over two days, we move from the Science and the Roadmap to the Economics and Implementation of a new human era.
A strategic blueprint for the industrialization of precision medicine and the integration of medical integrity with global capital.
The CLP Longevity Method™: Integrating Human Care and Precision Science
Defining the human-to-human dynamic in an AI-driven medical era, the strategic focus of the CLP Longevity Fund, and the evolution of at-home epigenetic hyper-customization.
Setting the Gold Standard: Evidence-Based Longevity Hubs
Presenting the International Institute’s framework for clinical excellence and the operational success of the Longevity Center in scaling precision diagnostics across Europe and Switzerland.
The Investment Frontier: Scaling Longevity Technologies
A venture capital perspective on the technologies driving personalized health management and the investment trends shaping the global longevity market.
The Microbiome-Longevity Axis: Decoding the Gut for Healthy Aging
Highlighting the critical link between metagenomic diversity and systemic vitality, and how precision microbiome mapping is becoming the cornerstone of personalized preventative medicine.
Rewriting the Genetic Narrative: Next-Gen Therapeutics
How small-molecule pharmacology and genetic reprogramming are moving from the lab to the clinic to intercept the hallmarks of aging and treat complex disorders.
National Scale, Individual Impact: The Biobanking Powerhouse
Why large-scale biological repositories are the "fuel" for the longevity industry, enabling the transition from population health to hyper-individualized clinical care.
Moving beyond static storage: How modern biobanks and large-scale data centres are transforming raw health data into the most valuable asset in the longevity economy.
An investor’s guide to the longevity economy: Identifying high-growth startups, navigating market entry, and building a scalable investment portfolio in health-tech markets.
A high-level strategic exchange on the transition from an "ageing society" to a "longevity society." This session defines the borderless ecosystem where health-independence is a fundamental right and the primary engine of global economic and social renewal.
Reimagining human purpose and social connection—moving beyond age-based stereotypes to build a collective "Republic" rooted in equity and shared intelligence.
Drawing on 25 years of global strategy to define the macro-economic pillars and $300 trillion investment potential required to sustain a longevity-first world.
Translating cellular rejuvenation into a universal standard—how epigenetic technologies serve as the technical foundation for future global health resilience.
